Pemigatinib
ATC L01EN02 · 10 markets · 32 records
US 6 records · 3 strengths
AU 4 records · 4 strengths
- 13.5 mgtabletPEMAZYRE pemigatinib 9 mg tablet blister pack
- 9 mgtabletPEMAZYRE pemigatinib 9 mg tablet blister pack
- 4.5 mgtabletPEMAZYRE pemigatinib 9 mg tablet blister pack
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 3 records · 3 strengths
CA 3 records · 3 strengths
SG 3 records · 3 strengths
ES 3 records · 3 strengths
TW 3 records · 3 strengths
HK 3 records · 1 strengths
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 3 records · 3 strengths
- 13.5 mgtabletPEMAZYRE 13,5 mg, comprimé
- 9 mgtabletPEMAZYRE 13,5 mg, comprimé
- 4.5 mgtabletPEMAZYRE 13,5 mg, comprimé
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|
| 13.5 mg tablet | Manufacturer: Lonza Tampa LLC ×3 PEMAZYRE | PEMAZYRE | PEMAZYRE | PEMAZYRE pemigatinib 9 mg tablet blister pack | PEMAZYRE | PEMAZYRE | PEMAZYRE 達伯坦錠13.5毫克 | PEMAZYRE 13,5 mg, comprimé | ||
| 9 mg tablet | Manufacturer: Lonza Tampa LLC ×3 PEMAZYRE | PEMAZYRE | PEMAZYRE | PEMAZYRE pemigatinib 9 mg tablet blister pack | PEMAZYRE | PEMAZYRE | PEMAZYRE 達伯坦錠9毫克 | PEMAZYRE 13,5 mg, comprimé | ||
| 4.5 mg tablet | Manufacturer: Lonza Tampa LLC ×3 PEMAZYRE | PEMAZYRE | PEMAZYRE | PEMAZYRE pemigatinib 9 mg tablet blister pack | PEMAZYRE | PEMAZYRE | PEMAZYRE 達伯坦錠4.5毫克 | PEMAZYRE 13,5 mg, comprimé | ||
unknown | PEMAZYRE | PEMAZYRE | PEMAZYRE |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.